Hikma Pharmaceuticals【HIK】銘柄情報

Hikma Pharmaceuticals Plc (HIK) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1,562.00

( -1.39% )

買値

1,562.00

売値

1,564.00

出来高

695,038

平均取引量 (3 か月)

814,302p

財務取引量

10,918,128p

1,556.00 日の範囲 1,587.00

1,187.00 52 週間の範囲 2,052.00

時価総額

3.328B

企業価値

5.767B

前日終値

1,584.00

始値

1,585.00

時刻

1562

(AT)

最終取引時間

21:43:45

VWAP

1,570.8678

歳入

3.35B

純利益

402M

発行済株式数

213,030,512

浮動株比率 (%)

67.82%

機関投資家保有比率 (%)

65.73%

配当利回り

0.84

PER

11.39

株価売上高倍率 (PSR)

1.31

1 株当たり利益 (EPS)

1.81

ベータ

0.65

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primari... Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom. 詳細を表示

セクター

Health Care

業界

ウェブサイト

www.hikma.com

本社

London, United Kingdom

設立

1978

Hikma Pharmaceuticals Plc is listed in the Health Care sector of the ロンドン証券取引所 with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,584p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,187.00p to 2,052.00p.

Hikma Pharmaceuticals currently has 213,030,512 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £3.33 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 11.39.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	1562	1761	1538	1461465	1623.13200042	DE
4	74	4.97311827957	1488	1761	1420	956397	1551.21634772	DE
12	177	12.7797833935	1385	1761	1311	860229	1476.48267512	DE
26	0	0	1562	1761	1187	1156893	1397.69962307	DE
52	-388	-19.8974358974	1950	2052	1187	918285	1509.95581507	DE
156	-267	-14.5981410607	1829	2360	1187	624981	1748.94903297	DE
260	-1049	-40.1761777097	2611	2703	1174.5	612485	1761.76154847	DE